ABT vs QTWO · P/E 25, rev $44.33B vs rev $696.5M
Abbott Laboratories (ABT) versus Q2 Holdings (QTWO) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Q2 Holdings (QTWO) is a software - application company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported QTWO revenue for 2024-12-31 was $696.5M. Net income was -$38.5M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. QTWO currently screens at market cap $5.77B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. QTWO currently screens at market cap $5.77B.
Not investment advice. Open the ABT and QTWO stock pages for the full models.
Not investment advice.